EVALUATION OF THE REAL-LIFE CONTRIBUTION OF VISIOCYT® BLADDER CYTOLOGY IN PATIENTS WITH SUSPECTED BLADDER TUMOR OR IN THE FOLLOW-UP OF A BLADDER TUMOR
Condition(s):Bladder CancerLast Updated:October 10, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Bladder CancerLast Updated:October 10, 2023Not yet recruiting
Condition(s):Hematological MalignancyLast Updated:February 20, 2024Not yet recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:December 18, 2023Not yet recruiting
Condition(s):Cancer Of PancreasLast Updated:December 21, 2023Not yet recruiting
Condition(s):PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREASLast Updated:August 21, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:August 14, 2023Not yet recruiting
Condition(s):Cancer of the ColonLast Updated:July 21, 2023Recruiting
Condition(s):Pancreatic Cancer Non-resectableLast Updated:April 6, 2023Not yet recruiting
Condition(s):Hematologic CancerLast Updated:November 1, 2022Not yet recruiting
Condition(s):Advanced or Metastatic Breast Cancer (BC)Last Updated:June 23, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.